| Date | Title | Description |
| 08.09.2021 | Strata Oncology Announces Publication of Analytical and Clinical Validation of StrataNGS® in the Journal of Molecular Diagnostics | |
| 23.08.2021 | New Publication Demonstrates Ability of StrataNGS® to Expand Proportion of Testable Tumor Tissue Samples for Precision Medicine | |
| 29.07.2021 | Robinhood has become a cultural moment. Now even bankers worry its IPO will be a meme-palooza | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
For better and for worse, it was stock-trading startup Robinhood that got the brunt of the attent... |
| 29.07.2021 | Robinhood has become a cultural moment. Now even bankers worry its IPO will be a meme-palooza | For better and for worse, it was stock-trading startup Robinhood that got the brunt of the attention from the meme-stock frenzy of recent months, rather than its rivals.
Robinhood is making its debut at a time when it is simultaneously belo... |
| 29.07.2021 | Strata Oncology Closes $90M Series C Financing | Strata Oncology, Inc., an Ann Arbor, Mich.-based precision oncology company advancing molecular indications for cancer therapies, raised $90m in Series C financing.
Wellington Management led the financing and was joined by other new investo... |
| 28.07.2021 | Strata Oncology Inks $90M Series C Financing |
ANN ARBOR, MI, Strata Oncology announced the completion of a $90 million Series C financing.
>> Click here for more funding data on Strata Oncology
>> To export Strata Oncology funding data to PDF and Excel, click here
St... |
| 28.07.2021 | Strata Oncology gets $90M boost from Pfizer, Merck and more for genomic cancer testing | Even after facing a robust attack by drugs and surgery, cancer cells can continue lurking deep within the body’s innermost layers of tissue. On a mission to journey through each stratum to uncover those hard-to-spot leftover cells, however,... |
| 28.07.2021 | Strata Oncology gets $90M boost from Pfizer, Merck and more for genomic cancer testing
Clinical Quality Oversight Forum | Even after facing a robust attack by drugs and surgery, cancer cells can continue lurking deep within the body’s innermost layers of tissue. On a mission to journey through each stratum to uncover those hard-to-spot leftover cells, however,... |
| 02.03.2021 | Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner | |
| 12.08.2019 | How Livongo Just Opened the Floodgate to a Digital Healthcare Wave | In the future, when we analyze moments in time when true innovation transformed an industry, we’ll remember an event that happened just a couple of weeks ago: Livongo’sIPO. By the end of its trading debut — which left the company valued at ... |
| 09.05.2019 | Don’t miss this innovation in cancer treatment conference in Philadelphia | A panel discussion will explore how precision medicine can be the key to population health. Experts from Cancer Treatment Centers of America, Color and other organizations will talk about the synergies between precision medicine and populat... |
| 30.05.2018 | Strata Oncology scores $26 million for large-scale next-generation sequencing | The company said it plans to use the funding to expand expand the pool of health systems using its platform; further develop its clinical-genomic data and software platforms; file with the Food and Drug Administration for approval of its St... |
| 25.05.2018 | Pfizer, Merck Lead Strata Oncology’s $26M Series B Round | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B investment round led ... |
| 24.05.2018 | Strata Oncology Receives $26M Series B Round |
ANN ARBOR, MI, Strata Oncology, a precision oncology platform company, today announced the close of a $26 million Series B funding round.
>> Click here for more funding data on Strata Oncology
>> To export Strata Oncology fu... |
| 24.05.2018 | Term Sheet — Thursday, May 24 | BIG BET
Big news out of the daily fantasy sports world.
Paid Content You can't secure what you can't see From ExtraHop
Under the agreement, Paddy Power will merge its U.S. assets with FanDuel and provide a further $158 million in cash. The ... |
| 23.05.2018 | Strata Oncology Secures $26M in Series B Funding | Strata Oncology, an Ann Arbor, Mich.-based precision oncology platform company, closed a $26m Series B funding round.
Backers included new investors Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management and Renaissance ... |
| 23.05.2018 | Pfizer, Merck invest $26 million in precision medicine startup Strata Oncology | The term precision medicine is often used interchangeably with the term “personalized medicine.” The two terms are related but not exactly the same. According to the Precision Medicine Initiative, precision medicine is “an emerging approach... |
| 23.05.2018 | Baird Capital Portfolio Company Strata Oncology Secures $26M in Series B Funding | Baird Capital portfolio company Strata Oncology, a Michigan-based precision oncology platform company, today announced the close of a $26 million USD Series B funding round. New investors Pfizer Ventures, Merck Global Health Innovation Fund... |
| 23.05.2017 | In landmark move, FDA approves cancer drug for a biomarker not a tissue | Colon, pancreatic, stomach, or ovarian cancer; it increasingly shouldn’t matter. In an era of precision medicine, the treatment approach should reflect the genetic makeup of the person’s tumor and the presence or absence of key biomarkers.
... |
| 21.12.2016 | How Strata plans to sequence 100K tumors for free | It begins with cancer patients and the unfortunate reality that personalized medicine hasn’t yet trickled down to everyday hospitals and clinics.
“The problem in the market today is that for most advanced cancer patients, tumor sequencing i... |
| 16.12.2016 | Baird Capital's Strata Oncology Launches Strata Trial with First Cancer Center Partners | Baird Capital portfolio company Strata Oncology today announced the launch of Strata Trial, a nationwide observational study providing no-cost tumor sequencing and clinical trial matching for 100,000 advanced cancer patients, to study the i... |
| 05.06.2016 | Strata Oncology Raises $12M Series A and Signs Strategic Partnership with Thermo Fisher Scientific | Strata Oncology, a precision medicine company, today announced the completion of a Series A financing of $12M. The financing will fuel Strata's state-of-the-art tumor sequencing operation and implementation of the Strata Trial, a nation-wid... |
| 02.06.2016 | Precision Medicine Company Strata Oncology Completes $12M Series A Financing | Strata Oncology, an Ann Arbor, Mich.-based precision medicine company, completed a $12M Series A financing.
The round was co-led by Arboretum Ventures and Baird Capital with additional funding provided by existing investor Michigan eLab.
Th... |
| 02.06.2016 | Strata Oncology Nets $12M |
ANN ARBOR, MI, Strata Oncology, a precision medicine company, today announced the completion of a Series A financing of $12M.
>> Click here for more funding data on Strata Oncology
>> To export Strata Oncology funding data t... |
| 01.06.2016 | Baird Capital co-leads Strata Oncology's $12M Series A financing | Ann Arbor-based Strata Oncology, a precision medicine company, completed a $12M Series A financing, co led by Arboretum Ventures and Baird Capital, with additional funding provided by Strata's existing investor, Michigan eLab. The financing... |
| - | How Strata plans to sequence 100K tumors for free | Strata Oncology might be the missing piece in personalized cancer care — if it can pull off some large-scale matchmaking.
Headquartered in Ann Arbor, Michigan, the company was founded earlier this year to address a number of critical indust... |
| - | In landmark move, FDA approves cancer drug for a biomarker not a tissue | Colon, pancreatic, stomach, or ovarian cancer; it increasingly shouldn’t matter. In an era of precision medicine, the treatment approach should reflect the genetic makeup of the person’s tumor and the presence or absence of key biomarkers.
... |
| - | Don’t miss this innovation in cancer treatment conference in Philadelphia | It feels like we’re on the cusp of great things in the development of cancer treatments. A wave of immunotherapy and gene therapy approvals could point the way forward in treating and curing certain forms of cancer. Pharma and technology co... |
| - | Strata Oncology scores $26 million for large-scale next-generation sequencing | A company developing next-generation sequencing for health care systems has raised a venture capital funding round led by two of the world’s largest drug companies.
Ann Arbor, Michigan-based Strata Oncology said last week that it had raised... |
